Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose N-Acetylcysteine in COPD and Chronic Bronchitis
NCT01599884Phase 2Unknown
- Sponsor
- Center for Veterans Research and Education
- Start
- Jun 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: St. George's Respiratory Questionnaire at 1 year. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT01599884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01599884.